Literature DB >> 1326083

A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells.

V Sullivan, C L Talarico, S C Stanat, M Davis, D M Coen, K K Biron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1326083     DOI： 10.1038/359085a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  21 in total

1.  Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.

Authors:  Edward Gershburg; Joseph S Pagano
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis.

Authors:  Mark N Prichard; William J Britt; Shannon L Daily; Caroll B Hartline; Earl R Kern
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 3.  The search for new therapies for human cytomegalovirus infections.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Virus Res       Date:  2010-11-21       Impact factor: 3.303

Review 4.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

5.  TAOK3 phosphorylates the methylenecyclopropane nucleoside MBX 2168 to its monophosphate.

Authors:  Gloria Komazin-Meredith; Steven C Cardinale; Katelyn Comeau; Kevin J Magalhaes; Caroll B Hartline; John D Williams; Timothy J Opperman; Mark N Prichard; Terry L Bowlin
Journal:  Antiviral Res       Date:  2015-04-07       Impact factor: 5.970

6.  Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.

Authors:  N S Lurain; A Weinberg; C S Crumpacker; S Chou
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

7.  Identification of mutation sites of a temperature-sensitive mutant of HCMV DNA polymerase activity.

Authors:  S Ihara; M Takekoshi; N Mori; S Sakuma; J Hashimoto; Y Watanabe
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Inhibition of cellular STAT3 synergizes with the cytomegalovirus kinase inhibitor maribavir to disrupt infection.

Authors:  Justin M Reitsma; Scott S Terhune
Journal:  Antiviral Res       Date:  2013-09-23       Impact factor: 5.970

9.  Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment.

Authors:  Dirk Kropeit; David McCormick; Katharina Erb-Zohar; Valentin S Moiseev; Zhanna D Kobalava; Hans-Peter Stobernack; Holger Zimmermann; Helga Rübsamen-Schaeff
Journal:  Br J Clin Pharmacol       Date:  2017-08-27       Impact factor: 4.335

10.  Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.

Authors:  Tarin M Bigley; Justin M Reitsma; Shama P Mirza; Scott S Terhune
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.